AENA:BMEAena SME SA Analysis
Data as of 2026-06-14 - not real-time
MX$498.26
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
AENA is trading at its 52‑week low of 498.26 MXN, right on the identified support level and below its 20‑day (509.46) and 50‑day (521.94) SMAs, signaling a short‑term price weakness. However, the RSI is ultra‑low at 2.5, suggesting the stock is deeply oversold, while the MACD remains bearish but the histogram is narrowing, hinting at a possible technical reversal. Volume trends are decreasing and 30‑day volatility is elevated at ~18%, yet the computed beta is essentially zero, indicating minimal market‑wide price swings.
Fundamentally, AENA delivers exceptional profitability with a gross margin of 80% and an operating margin above 30%, while ROE stands at 24% and ROA at 10%. The PE ratio of 17.3 is well below the industry average of 30.6, and the dividend yield of 4.46% is supported by a 68% payout ratio and robust free cash flow. Leverage is a concern (debt‑to‑equity ~83%), but the company’s cash position and cash‑flow generation provide a cushion. Overall, the stock appears undervalued with strong cash returns and a resilient business model.
Fundamentally, AENA delivers exceptional profitability with a gross margin of 80% and an operating margin above 30%, while ROE stands at 24% and ROA at 10%. The PE ratio of 17.3 is well below the industry average of 30.6, and the dividend yield of 4.46% is supported by a 68% payout ratio and robust free cash flow. Leverage is a concern (debt‑to‑equity ~83%), but the company’s cash position and cash‑flow generation provide a cushion. Overall, the stock appears undervalued with strong cash returns and a resilient business model.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI at 2.5 indicates extreme oversold condition
- Price is at technical support of 498.26 MXN
- Decreasing volume and elevated short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong profitability margins and high ROE
- Undervalued relative to industry PE (17.3 vs 30.6)
- Attractive dividend yield with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Consistent free cash flow supporting dividend sustainability
- Low market beta suggesting defensive characteristics
- Diversified geographic footprint reducing single‑country exposure
Key Metrics & Analysis
Financial Health
Revenue Growth11.80%
Profit Margin33.51%
P/E Ratio17.3
ROE24.40%
ROA10.16%
Debt/Equity83.47
P/B Ratio3.9
Op. Cash FlowMX$2.9B
Free Cash FlowMX$1.4B
Industry P/E30.6
Technical Analysis
TrendNeutral
RSI2.5
SupportMX$498.26
ResistanceMX$530.26
MA 20MX$509.46
MA 50MX$521.94
MA 200MX$509.39
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair ValueMX$17.37
GradeUndervalued
TypeBlend
Dividend Yield4.46%
Risk Assessment
Beta0.01
Volatility18.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.